Table 1.
Clinical characteristics of COVID-19 patients with and without asthma.
| Characteristic | Asthma (n = 562) | No asthmaa (n = 2686) | p-value |
|---|---|---|---|
| Age (mean, SD, years) | 51 (17) | 51 (17) | |
| 26–35 | 79 (14) | 388 (14) | |
| 36–45 | 115 (20) | 564 (21) | |
| 46–55 | 127 (23) | 608 (23) | |
| 56–65 | 126 (22) | 598 (22) | |
| 66–75 | 69 (12) | 322 (12) | |
| 76–85 | 32 (6) | 139 (5) | |
| 86–95 | 12 (2) | 57 (2) | |
| >95 | 2 (<1) | 10 (< 1) | |
| Sex, female | 404 (72) | 1933 (72) | |
| Race | 0.003 | ||
| White | 303 (54) | 1247 (46) | |
| Black | 95 (17) | 475 (18) | |
| Asian | 10 (2) | 100 (4) | |
| Other | 154 (27) | 864 (32) | |
| Ethnicity | <0.001 | ||
| Hispanic | 176 (31) | 856 (32) | |
| Non-Hispanic | 368 (65) | 1595 (59) | |
| Unknown | 18 (3) | 235 (9) | |
| Payor | <0.001 | ||
| Private | 343 (61) | 1584 (59) | |
| Public | 213 (38) | 937 (35) | |
| Other | 6 (1) | 165 (6) | |
| Body mass index (mean, SD, kg/m2) | 31.8 (7.2) | 29.8 (6.4) | <0.001 |
| <18.5 | 8 (1) | 681 (25) | |
| 18.5–24.9 | 77 (14) | 459 (17) | |
| 25–29.9 | 157 (28) | 659 (25) | |
| 30–34.9 | 160 (28) | 503 (19) | |
| 35–39.9 | 96 (17) | 249 (9) | |
| ≥40 | 64 (11) | 135 (5) | |
| Smoking status | <0.001 | ||
| Never | 385 (69) | 1621 (60) | |
| Former | 141 (25) | 432 (16) | |
| Current | 30 (5) | 101 (4) | |
| Unknown | 6 (1) | 532 (20) | |
| Diabetes | 99 (18) | 222 (8) | <0.001 |
| Hypertension | 36 (6) | 71 (3) | <0.001 |
| Congestive heart failure | 13 (2) | 30 (1) | 0.02 |
| Severe renal disease | 7 (1) | 23 (<1) | 0.38 |
| Sickle cell disease | 3 (<1) | 5 (<1) | 0.15 |
| Charlson comorbidity indexb | 2.1 (2.5) | 1.0 (2.1) | <0.001 |
COVID-19, coronavirus disease 2019; SD, standard deviation.
Data are represented by mean ± standard deviation or number (percentage) unless otherwise indicated. Text in boldface indicates statistical significance, p < 0.05.
a
Age, sex, and date of SARS-CoV-2 diagnosis matched comparators.
b
See eTables 1 and 3 for ICD-10-CM codes and scoring system.